Clincosm LogoSign in Get a demo

high grade serous ovarian cancer

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, Endometrial Cancer Trial in Oklahoma City, Houston (AO-252)

Recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Oklahoma City, Oklahoma
  • +1 more
Nov 13, 2023

High Grade Serous Ovarian Cancer Trial in Montpellier (Blood sample and tissue sample)

Not yet recruiting
  • High Grade Serous Ovarian Cancer
  • Blood sample and tissue sample
  • Montpellier, France
    NOUGARET Stephanie
Oct 10, 2023

High Grade Serous Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Cambridge (Upifitimab rilsodotin,

Recruiting
  • High Grade Serous Ovarian Cancer
  • +2 more
  • Upifitimab rilsodotin
  • Placebo
  • Phoenix, Arizona
  • +40 more
Jan 25, 2023

Endometrioid Cancer, Mucinous Ovarian Cancer, High Grade Serous Ovarian Cancer Trial in Oklahoma City (VS-6766 + defactinib)

Not yet recruiting
  • Endometrioid Cancer
  • +3 more
  • VS-6766 + defactinib
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Aug 19, 2022

Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound,

No longer available
  • Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound
  • +3 more
  • (no location specified)
May 20, 2022

miRNAs in High Grade Serous Ovarian Cancer

Recruiting
  • High Grade Serous Ovarian Cancer
    • Bologna, Bo, Italy
      IRCCS- Azienda Ospedaliera-Universitaria di Bologna
    Dec 3, 2021

    High Grade Serous Ovarian Cancer Trial in Roma (Olaparib, Paclitaxel, Carboplatin)

    Recruiting
    • High Grade Serous Ovarian Cancer
    • Roma, Italy
      Fondazione Policlinico Gemelli IRCCS
    Feb 6, 2020

    Oncology, BRCA Mutated, High Grade Serous Ovarian Cancer Trial (Veliparib)

    Completed
    • Oncology
    • +3 more
    • (no location specified)
    Nov 17, 2017